Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-27 @ 4:43 AM
Study NCT ID:
NCT00582803
Status:
COMPLETED
Last Update Posted:
2009-07-10
First Post:
2007-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adherence to Intensive Surveillance for Hereditary Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
03-059
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mark Robson, MD
Old Organization:
Memorial Sloan-Kettering Cancer Center
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |